Note: Viome Life Sciences's revenues are gauged from an analysis of company filings.
Viome Life Sciences's Income Statement (based on Industry Averages)
Viome Life Sciences P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Viome Life Sciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
October 11, 2022
34
69%
$97 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Viome Life Sciences is developing and marketing.
Viome Life Sciences's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ORAL HEALTH PRO diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer and pre-malignant conditions, dental and gum disease, throat disease, and risk factors for oral, throat, and systemic disease conditions; diagnostic kits comprised of medical diagnostic reagents and assays for providing insights to help personalize medical and dental treatment plans; medical diagnostic test kits for saliva analysis
06/09/2023
VRX MY·BIOTICS non-medicated lozenges
05/05/2023
YOU, DECODED Providing information in the fields of personalized health, wellness, nutrition, gut microbiome analysis, gut gene expression analysis, and gut metabolite analysis via a website; health assessment services
03/29/2022
See all trademarks and details in the Full Report.
Market Share of Viome Life Sciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Viome Life Sciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Viome Life Sciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Viome Life Sciences's Fastest Growing Competitors
These companies are in the same general field as Viome Life Sciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.